Abstract: In response to the contradiction between high throughput and low hardware overhead faced by data encryption in Network on Chip (NoC) communication, this paper proposes a lightweight AES ...

Redacted documents are shown in a photo illustration in Washington, D.C., on Dec. 19, after the Justice Department began releasing records from its investigation into convicted sex offender Jeffrey ...

INDIANAPOLIS — AES Indiana has filed with regulators to reduce rates for customers. The company says the average ratepayer could save about $4 a month if the change is approve. AES filed the rate ...

INDIANAPOLIS — AES Indiana filed for a decrease in its quarterly Fuel Adjustment Charge with state regulators. If approved by the Indiana Utility Regulatory Commission (IURC), the monthly bill for a ...

bitrat is a command-line tool to quickly calculate checksums for nested file hierarchies, such that subsequent changes to those files can be easily detected, with the goal of identifying files ...

Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...

Meta is giving Instagram users a rare glimpse into why certain posts are showing up on their Reels, the platform’s feed of algorithmically curated videos. Starting today, users will now see a list of ...

Users can note which content they would like to view more frequently. Instagram is handing users some control in deciding what content they see. The social media giant is allowing users to have a say ...

(p < 0.0002), 66% increase in motor seizure-free days (p = 0.0340), broad and clinically meaningful functional improvements (p ≤ 0.002) Patients in the RADIANT study of vormatrigine showed rapid, ...

Abstract: Due to the advancement of technology, information security and user privacy have become a critical issue resulting in the use of various encryption techniques. Especially with the increasing ...

VALBY, Denmark, Dec. 6, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced results from a long-term follow-up in patients who have received bexicaserin (LP352) for up to two years.